Pfizer Vaccine, Election Impact & Ant Financial IPO

CNBC's Bob Pisani spoke with Nick Colas, co-founder of DataTrek Research, Matt Bartolini, Head of SPDR Americas Research at State Street Global Advisors and Brendan Ahern, CIO of KraneShares. They discussed the monster rally we’re seeing on the back of Pfizer’s vaccine news, election impact and what Ant Financial’s IPO debacle means for the Chinese ETF market. In the 'markets 102' segment, Bob discusses the strength of the rally and how sustainable the momentum is going into year-end.

Om Podcasten

ETFs (exchange-traded funds) are one of the fastest growing trends in investing and now ETF Edge has you covered. Each week, CNBC's Stocks Editor Bob Pisani is joined by top market participants offering educational and actionable advice to help you build your best portfolio. And, at the end of each episode, stick around for our 'Markets 102' segment where we round out the conversation with some thoughtful, in-depth analysis and perspective to help you better understand ETFs, and put it in the context of today's markets.